“Bloomberg ETF IQ” focuses on the opportunities, risks and current trends tied to the trillions of dollars in the global exchange traded funds industry. Today’s guests: Strategas ETF Strategist Todd Sohn, TMX VettaFi Head of Sector & Industry Research Roxanna Islam, AdvisorShares CIO & Portfolio Manager Dan Ahrens, and PIMCO Head of Leveraged Finance David Forgash. (Source: Bloomberg)
Global oil prices finished on a mixed note while U.S. crude prices edged higher Thursday, reacting to news of progress toward a deal that would extend the U.S.-Iran cease-fire.
The Protect College Sports Act bill could ‘materially harm the earnings potential of top college athletes,’ one sports attorney says.
Canadian online brokerages Wealthsimple and Questrade Inc. are joining a wave of companies promising to offer access to firms planning initial public offerings, as startup funding rounds heat up.
Treasury Secretary Scott Bessent said that President Trump will not make a bad deal with Iran amid reports of a 60-day truce extension waiting the president’s approval. Bessent, speaking at the White House press briefing, outlined President Trump’s conditions for a deal with Iran, saying that for a deal to happen the country must agree to open the Strait of Hormuz, turn over its enriched uranium and not to pursue a nuclear weapon. (Source: Bloomberg)
David Forgash, managing director and head of leveraged finance at Pimco, joins Dani Burger on “Bloomberg ETF IQ.” They speak at the Goldman Sachs Annual Leveraged Finance Conference in Dana Point, California. (Source: Bloomberg)
Dan Ahrens, CIO & portfolio manager at AdvisorShares, joins Katie Greifeld and Eric Balchunas on “Bloomberg ETF IQ.” They discuss the AdvisorShares Psychedelics ETF (ticker: PSIL). (Source: Bloomberg)
Todd Sohn, ETF strategist at Strategas, joins Katie Greifeld and Eric Balchunas on “Bloomberg ETF IQ.” Nasdaq instituted a rule change that shortens the time for newly public companies to be added to its index, while S&P Dow Jones and FTSE Russell are considering similar changes. This comes ahead of expected mega IPOs from SpaceX, OpenAI and Anthropic. (Source: Bloomberg)
A $65 billion Series H funding round follows a sharp three-month revenue surge for the Claude creator, pushing Anthropic to a fresh $965 billion valuation.
That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.
